LUMOS
LIVE

Serial Number

79289194

Owner

LUMOS DIAGNOSTICS IP PTY LTD

Attorney

Paulo A. de Almeida

Filing Date

May 13, 2020

Add to watchlist:

No watchlists yet
View on USPTO

LUMOS Trademark

Serial Number: 79289194 • Registration: 7430867

LUMOS is a trademark filed by LUMOS DIAGNOSTICS IP PTY LTD on May 13, 2020. The trademark is classified under Class 1 (Chemicals), Class 9 (Computers & Electronics), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

LUMOS DIAGNOSTICS IP PTY LTD (2 trademarks)

436 Elgar Road
Box Hill, Victoria 3128 , AU

Entity Type: 99

Trademark Details

Filing Date

May 13, 2020

Registration Date

July 2, 2024

Published for Opposition

April 16, 2024

Goods & Services

Assay readers for non-medical or non-veterinary use, namely microplate readers and diagnostic apparatus for the detection of pathogens for laboratory or research use in the nature of lateral flow readers; assaying instruments namely, test tubes, pipettes, pipette racks and pipette tips all for laboratory use; scientific instruments, namely, clinical chemistry analysers, namely, lateral flow readers, other than for medical or veterinary use, for testing and analyzing chemical substances for the presences, absence, or quantity of chemicals, biologics, and contaminants; scientific apparatus and instruments using dna, genetic and other biological and diagnostic materials, namely, chips and sensor chips having multi-well arrays that can be used in chemical analysis, biological analysis or patterning for scientific, laboratory or medical research use; non-medical diagnostic testing instruments for use in immunoassay procedure, namely, electronic analyzers, namely, lateral flow readers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of chemical and biological markers; invitro diagnostic testing apparatus other than for medical use, namely, electronic analyzers, namely, lateral flow readers for testing and analyzing biological substances for the presence, absence, or quantity of biological markers; recorded and downloadable computer software in the field of diagnostics and in relation to diagnostic and assay products for communication and transmission of data; none of the aforesaid goods being microscopes, spectrometers or interferometers

Business advisory services relating to diagnostic and assay product development; business development services in relation to diagnostic and assay products; business development of inventions in relation to diagnostic and assay products; business intermediary services relating to the commercialization of diagnostic and assay goods, specifically the matching of potential private investors with entrepreneurs needing funding; business consultation in relation to diagnostic and assay products; business consultancy services relating to manufacturing of diagnostic and assay products; manufacturer's representative services in relation to diagnostic and assay products

Chemical preparations for diagnostic purposes other than for medical or veterinary purposes; chemical diagnostic reagents for scientific use; chemical preparations for industrial diagnostic use; chemical preparations for scientific diagnostic use; dna, genetic and other biological and diagnostic materials, namely, biological tissue cultures other than for medical or veterinary purposes, biological preparations for use in industry and science, all for non-medical and non-veterinary use in chips, arrays and sensors; diagnostic preparations for laboratory use, other than medical; diagnostic preparations for scientific purposes; diagnostic preparations, other than for medical or veterinary purposes; diagnostic reagents for scientific use; diagnostic reagents for scientific or research use, other than for medical laboratory use; diagnostic preparations, other than for medical use; chemical test paper for use with assays; chemicals for use in immuno-assay testing other than for medical or veterinary use; immunoassay reagents, other than for medical use; chemical diagnostic reagents for scientific use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 4, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 12, 2024 FICS
FINAL DISPOSITION PROCESSED
Dec 12, 2024 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 2, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 2, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 2, 2024 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 16, 2024 NPUB
PUBLISHED FOR OPPOSITION
Apr 16, 2024 PUBO
NOTIFICATION PROCESSED BY IB
Apr 15, 2024 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 27, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 27, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 27, 2024 OP2R
EXPARTE APPEAL TERMINATED
Mar 8, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 8, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 16, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 16, 2024 CRFA
ASSIGNED TO LIE
Feb 16, 2024 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 27, 2023 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jun 4, 2023 NREP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 26, 2023 GNRN
NON-FINAL ACTION E-MAILED
May 26, 2023 GNRT
NON-FINAL ACTION WRITTEN
May 26, 2023 CNRT
EX PARTE APPEAL-INSTITUTED
May 2, 2023 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
May 2, 2023 JURT
EXPARTE APPEAL RECEIVED AT TTAB
May 2, 2023 EXAF
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 1, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Nov 1, 2022 GNFN
FINAL REFUSAL E-MAILED
Nov 1, 2022 GNFR
FINAL REFUSAL WRITTEN
Nov 1, 2022 CNFR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Apr 12, 2022 RCSC
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 1, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 15, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 15, 2021 OPNR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 12, 2021 RCSC
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Apr 21, 2021 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Apr 3, 2021 LIMG
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 25, 2021 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 25, 2021 GNSL
SUSPENSION LETTER WRITTEN
Mar 25, 2021 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 11, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2021 TROA
REFUSAL PROCESSED BY IB
Sep 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 10, 2020 RFCS
REFUSAL PROCESSED BY MPU
Sep 10, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 14, 2020 RFCR
NON-FINAL ACTION WRITTEN
Aug 13, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 10, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 14, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 10, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 9, 2020 REPR